Mazen Animal Health

Mazen Animal Health harnesses the power of plant biotechnology to create orally delivered biologics, aimed at significantly improving animal health and welfare. The company's innovative cross-species platform is versatile enough to target various animals, including swine, poultry, livestock, aquaculture, pets, and wildlife. By utilizing molecular farming, Mazen develops plant-based vaccines that can be administered through animal feed, replacing the need for injectable vaccines. This advancement not only reduces the cost of animal production but also enhances worker safety, animal welfare, and biosecurity. Their technology promises substantial growth in the $50 billion global animal health market by minimizing losses and benefiting the environment. With demonstrated efficacy in swine and poultry, Mazen is progressing through regulatory approvals for commercialization. Their diverse team of experts in biotechnology, production, animal vaccines, and business is supported by an experienced board specializing in agriculture, industry, and investments.